SARAH BREND: Open Payments
NPI 1780988600 · DAKOTA DUNES, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 40 payments from 18 companies in 2025. Trend: 2023 $665 · 2024 $577 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 16 | $171 |
| UROGEN PHARMA, INC. | 2 | $53 |
| PFIZER INC. | 2 | $50 |
| Ferring Pharmaceuticals Inc. | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| TOLMAR, INC. | 2 | $39 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $32 |
| Janssen Biotech, Inc. | 1 | $28 |
| Procept Biorobotics Corporation | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
Products named: ORGOVYX, XTANDI, ZUSDURI, ADSTILADRIN, GEMTESA, Nubeqa, YONSA, ERLEADA.
Industry payments across SD — which companies pay providers there.
